Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF Induction Chemotherapy for Low Stathmin OSCC
NCT03326947Phase 2Recruiting
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jan 2018
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin, fluorouracil in oral squamous cell carcinoma (OSCC), sponsored by Shanghai Jiao Tong University School of Medicine. Started Jan 2018; status: recruiting.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
oral squamous cell carcinoma (OSCC)
Beyond the preview
Go deeper on NCT03326947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03326947.